These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
550 related articles for article (PubMed ID: 31416447)
1. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A. Lee BH; Lee DS; Cho CW; Yun SS World J Surg Oncol; 2019 Aug; 17(1):143. PubMed ID: 31416447 [TBL] [Abstract][Full Text] [Related]
2. Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination. Kuramoto K; Beppu T; Nitta H; Imai K; Masuda T; Miyata T; Koga Y; Kitano Y; Kaida T; Nakagawa S; Okabe H; Hayashi H; Hashimoto D; Yamashita YI; Chikamoto A; Kikuchi K; Baba H Anticancer Res; 2018 Jan; 38(1):525-531. PubMed ID: 29277819 [TBL] [Abstract][Full Text] [Related]
3. Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma. Pan Y; Mei J; Chen J; Zhang D; Wang J; Wang X; Yi M; Zhou Z; Zhang Y; Chen M; Guo R; Xu L Ann Surg Oncol; 2022 Mar; 29(3):2016-2029. PubMed ID: 34637058 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment. Hsiao JH; Tsai CC; Liang TJ; Chiang CL; Liang HL; Chen IS; Chen YC; Chang PM; Chou NH; Wang BW Int J Surg; 2017 Sep; 45():35-41. PubMed ID: 28728985 [TBL] [Abstract][Full Text] [Related]
5. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma. Kawaoka T; Aikata H; Hyogo H; Morio R; Morio K; Hatooka M; Fukuhara T; Kobayashi T; Naeshiro N; Miyaki D; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Waki K; Tsuji K; Kohno H; Kohno H; Moriya T; Chayama K J Dig Dis; 2015 Sep; 16(9):505-12. PubMed ID: 26121102 [TBL] [Abstract][Full Text] [Related]
6. Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report. Sano S; Nakata S; Wada S; Kuroiwa M; Sakai H; Kusama K; Machida T; Nishio A; Ito I; Sodeyama H World J Surg Oncol; 2019 Dec; 17(1):229. PubMed ID: 31878937 [TBL] [Abstract][Full Text] [Related]
7. Significance of hepatic resection and adjuvant hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombus in the first branch of portal vein and the main portal trunk: a project study for hepatic surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. Hatano E; Uemoto S; Yamaue H; Yamamoto M; J Hepatobiliary Pancreat Sci; 2018 Sep; 25(9):395-402. PubMed ID: 30091239 [TBL] [Abstract][Full Text] [Related]
8. Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy. Niizeki T; Sumie S; Torimura T; Kurogi J; Kuromatsu R; Iwamoto H; Aino H; Nakano M; Kawaguchi A; Kakuma T; Sata M J Gastroenterol; 2012 Jun; 47(6):686-95. PubMed ID: 22382631 [TBL] [Abstract][Full Text] [Related]
9. Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma. Han S; Choi HJ; Beom SH; Kim HR; Lee H; Lee JS; Lee HW; Park JY; Kim SU; Kim DY; Ahn SH; Han KH; Seong J; Won JY; Kim BK J Cancer Res Clin Oncol; 2021 Oct; 147(10):3123-3133. PubMed ID: 33893539 [TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma. Kim DY; Ahn SH; Kim SU; Choi SB; Lee KH; Park MS; Park JY; Lee DY; Han KH; Kim KS Oncology; 2011; 81(3-4):184-91. PubMed ID: 22067673 [TBL] [Abstract][Full Text] [Related]
12. Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma. Park JY; Ahn SH; Yoon YJ; Kim JK; Lee HW; Lee DY; Chon CY; Moon YM; Han KH Cancer; 2007 Jul; 110(1):129-37. PubMed ID: 17508408 [TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma. Kim BK; Park JY; Choi HJ; Kim DY; Ahn SH; Kim JK; Lee DY; Lee KH; Han KH J Cancer Res Clin Oncol; 2011 Apr; 137(4):659-67. PubMed ID: 20552225 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic hepatic artery infusion chemotherapy improved survival after curative resection in patients with hepatocellular carcinoma. Huang SX; Wu YL; Tang CW; Feng WM; Xu YQ; Bao Y; Zheng YY Hepatogastroenterology; 2015; 62(137):122-5. PubMed ID: 25911881 [TBL] [Abstract][Full Text] [Related]
15. Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial. Kondo M; Morimoto M; Kobayashi S; Ohkawa S; Hidaka H; Nakazawa T; Aikata H; Hatanaka T; Takizawa D; Matsunaga K; Okuse C; Suzuki M; Taguri M; Ishibashi T; Numata K; Maeda S; Tanaka K BMC Cancer; 2019 Oct; 19(1):954. PubMed ID: 31615466 [TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma according to Child-Pugh classification. Miyaki D; Aikata H; Honda Y; Naeshiro N; Nakahara T; Tanaka M; Nagaoki Y; Kawaoka T; Takaki S; Waki K; Hiramatsu A; Takahashi S; Ishikawa M; Kakizawa H; Awai K; Chayama K J Gastroenterol Hepatol; 2012 Dec; 27(12):1850-7. PubMed ID: 23020312 [TBL] [Abstract][Full Text] [Related]
18. A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma. Song MJ; Bae SH; Chun HJ; Choi JY; Yoon SK; Park JY; Han KH; Kim YS; Yim HJ; Um SH; Chung WJ; Hwang JS; Cho SB; Eun JR Cancer Chemother Pharmacol; 2015 Apr; 75(4):739-46. PubMed ID: 25663125 [TBL] [Abstract][Full Text] [Related]
19. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy. Kanekawa T; Nagai H; Kanayama M; Sumino Y Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286 [TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy. Miyaki D; Aikata H; Kan H; Fujino H; Urabe A; Masaki K; Fukuhara T; Kobayashi T; Naeshiro N; Nakahara T; Kawaoka T; Hiramatsu A; Takahashi S; Ishikawa M; Kakizawa H; Awai K; Chayama K J Gastroenterol Hepatol; 2013 Dec; 28(12):1834-41. PubMed ID: 23808713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]